Skip to main content
Premium Trial:

Request an Annual Quote

Samsung SDS Seeks Participants to Test-Drive New Genome Analysis Service

Premium

Samsung SDS, a subsidiary of the Samsung group, plans to kick off beta testing of its new next-generation sequencing cloud-based data analysis service on Sept. 1, BioInform learned this week.

The beta is expected to last until November. As part of the test, the firm is offering to analyze one genome per researcher for free.

The company offers NGS analysis services including mapping, gene expression, alternative splicing, and fusion transcripts, among other applications for whole genome sequencing with a turnaround time of seven days; and for RNA-seq, with a turnaround time of three days.

The service accepts data from Life Technologies SOLiD 3 Plus, and SoLiD 4; Illumina's Genome Analyzer; and the HiSeq 1000 and 2000 platforms.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more